US-based wound care center operator Healogics gets $240m investment

Healogics, a US-based chain of wound care centers, has secured a new equity investment of $240 million.

Clayton Dubilier & Rice, Northwestern Mutual, and Partners Group, on behalf of its clients, have led a group of new and existing investors for investing $75 million of common equity.

On the other hand, Marathon Asset Management has invested more than $165 million in new preferred stock.

David Bassin – CEO of Healogics said: “This transaction demonstrates strong support and confidence in Healogics’s business and long-term growth plan.

“With this new capital, we are well-positioned to further improve our operational capacity to expand the reach of our essential care to patients in need.”

US-based wound care center operator Healogics gets $240m investment

The wound care center operator also got a new revolving credit facility of $30 million and a new first lien term loan of $370 million, both led by J.P. Morgan’s Strategic Situations.

The financing led to an extension of Healogics’ debt maturity schedule, with no significant maturities before 2025.

Healogics, which has a network of more than 600 wound care centers, also partners with more than 300 nursing facilities to care for patients having chronic wounds, while offering inpatient consults at over 60 partner hospitals.